Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill Patients

NCT00571649 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

8101

Enrollment

INDUSTRY

Sponsor class

Conditions

Venous Thromboembolism

Interventions

DRUG: Rivaroxaban (Xarelto, BAY59-7939)
DRUG: Enoxaparin
DRUG: Rivaroxaban placebo
DRUG: Enoxaparin placebo

Sponsor

Bayer

Collaborators

[object Object]